- WHO non-Hodgkin's lymphoma classification by criterion-based report review followed by targeted pathology review: an effective strategy for epidemiology studiesJennifer J Turner
Department of Anatomical Pathology, St Vincent s Hospital, Level 6, Xavier Building, Darlinghurst, New South Wales, Australia
Cancer Epidemiol Biomarkers Prev 14:2213-9. 2005....
- InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directionsJennifer J Turner
Department of Histopathology, Douglass Hanly Moir Pathology, and the Australian School of Advanced Medicine, Macquarie University, Sydney, Australia
Blood 116:e90-8. 2010..We encourage epidemiologists to adopt the updated InterLymph hierarchical classification, which incorporates the most recent WHO entities while demonstrating their relationship to older classifications...
- Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphomaAnn Maree Hughes
School of Public Health, University of Sydney, Sydney, Australia
Int J Cancer 110:429-34. 2004..5- to 2-fold increases in risk but with wide confidence intervals. These results provide weak support for the possibility that sun sensitivity or perhaps sun exposure increases risk of NHL...
- Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysisClaire M Vajdic
University of New South Wales Cancer Research Center, Prince of Wales Clinical School and National Center in HIV Epidemiology and Clinical Research, University of New South Wales, and Prince of Wales Hospital, Randwick, New South Wales, Australia
Cancer Res 69:6482-9. 2009..This pooled study shows evidence of a modest but consistent reduction in the risk of B-cell NHL associated with atopy...
- Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profilingTo Ha Loi
Blood Stem Cell and Cancer Research Unit, Department of Haematology, St Vincent s Hospital, Victoria Street, Darlinghurst, Australia
BMC Med Genomics 4:27. 2011..In this proof of principle study, gene expression microarray was evaluated as a single platform test in the differential diagnosis of common lymphoma subtypes and reactive lymphadenopathy (RL) in lymph node biopsies...